Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Hillson K. et al, (2021), The Lancet, 398, 1683 - 1684

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Flaxman A. et al, (2021), The Lancet, 398, 981 - 990

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Emary KRW. et al, (2021), The Lancet, 397, 1351 - 1362

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.

Bitencourt J. et al, (2021), Frontiers in immunology, 12

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Ramasamy MN. et al, (2020), The Lancet, 396, 1979 - 1993

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.

Arrieta O. et al, (2020), JAMA oncology, 6, 856 - 864

Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries.

Cardona AF. et al, (2020), Therapeutic advances in respiratory disease, 14

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components

Fedosyuk S. et al, (2019), Vaccine, 37, 6951 - 6961

Cancer immunotherapy-associated hypophysitis.

Castillero F. et al, (2019), Future oncology (London, England), 15, 3159 - 3169

The use of immunotherapy for the treatment of tuberculosis.

Ramos-Espinosa O. et al, (2018), Expert review of respiratory medicine, 12, 427 - 440

Include forthcoming?